As the 58th Brazilian Congress of Clinical Pathology / Laboratory Medicine (CBPC/ML) convenes from 15–18 September 2026 at CentroSul in Florianópolis, Goldsite Diagnostics Inc. warmly invites pathologists, laboratory directors, clinicians, and healthcare decision-makers to visit Booth 129. This premier gathering of clinical pathology and laboratory medicine professionals in Brazil and Latin America offers a vital platform to strengthen partnerships, share evidence-based innovations, and accelerate the delivery of precise, accessible diagnostics that improve patient outcomes across the region.

Join Us at Booth 129

We invite you to experience live demonstrations, discuss your laboratory’s specific requirements with our technical and commercial experts, and explore partnership opportunities that can strengthen diagnostic capacity across Brazil and Latin America. Special promotions and personalized consultations will be available for congress attendees. Book a meeting in advance via our website or simply stop by Booth 129 during the exhibition days.

Who We Are: A Trusted Partner in In Vitro Diagnostics Since 1999

Goldsite Diagnostics Inc., founded in 1999 and headquartered in Shenzhen, China, is a leading manufacturer dedicated exclusively to the research, development, manufacturing, and global marketing of in vitro diagnostic (IVD) solutions. With more than 27 years of specialized expertise, over 20,000 hospital and laboratory users worldwide, installations in more than 100 countries, and a consistent commitment of approximately 20% of annual revenue to R&D, Goldsite has built a reputation for reliable, high-performance technologies that meet real clinical needs.

Our ISO 9001 and ISO 13485 certified facilities, combined with international recognitions including CE, NGSP, IFCC, and MHRA, underscore a rigorous quality culture. We invest in continuous innovation across instrument and reagent platforms so that laboratories—from high-volume reference centers to resource-constrained clinics—can deliver accurate results efficiently and affordably. Our vision remains clear: to enhance patient care and health outcomes by making state-of-the-art diagnostics more accessible globally, with a particular focus on expanding meaningful collaborations throughout Latin America.

What We Offer:

Our Core Solutions & Services

• High-Performance Liquid Chromatography (HPLC) Platforms: Specialized systems engineered for precise HbA1c quantification, hemoglobin variant detection, and thalassemia screening—providing gold-standard accuracy for diabetes and hematology management.

• Point-of-Care Testing (POCT) & Specific Protein Analyzers: Nephelometric and multi-wavelength optical platforms designed for rapid, on-site testing of clinical biomarkers, including inflammatory indicators, immunoglobulins (IgG, IgM), and kidney injury markers (such as microalbuminuria).

• Automated Hematology Systems: Reliable cell counters designed to optimize daily laboratory workflows while maintaining high analytical throughput.

• End-to-End Operational Support: Reagent supply security, technical installation, laboratory workflow consulting, and dedicated local maintenance services.

An Invitation to Connect at CBPC/ML 2026

Goldsite Diagnostics invites all attendees, hospital executives, distributors, and laboratory professionals to visit our booth during CBPC/ML 2026 in Rio de Janeiro.

Whether you are looking to expand your laboratory’s diagnostic menu, upgrade to gold-standard HbA1c testing, or establish strategic distribution partnerships in Latin America, our team is ready to connect and explore collaborative growth.